Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
202.20
+3.68 (1.85%)
Sep 1, 2026, 10:14 AM EDT - Market open
Axsome Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -191.64 | -183.17 | -287.22 | -239.24 | -187.13 | -130.4 |
Depreciation & Amortization | 9.94 | 9.06 | 7.96 | 6.83 | 4.4 | 0.08 |
Other Amortization | 0.64 | 1.3 | 2.64 | 2.57 | 1.48 | 1.08 |
Stock-Based Compensation | 96.42 | 93.75 | 85.22 | 62.62 | 37.73 | 20.8 |
Other Operating Activities | 6.53 | 8.71 | 29.51 | 50.37 | 3.34 | -0.1 |
Change in Accounts Receivable | -78.63 | -82.46 | -47.18 | -57.12 | -37.7 | - |
Change in Inventory | -17.63 | -10.66 | 0.74 | -8.16 | -1.33 | - |
Change in Accounts Payable | -12.66 | -6.46 | 31.32 | 2.07 | 25.46 | -0.36 |
Change in Other Net Operating Assets | 115.79 | 76.53 | 48.6 | 34.97 | 37.24 | 0.68 |
Operating Cash Flow | -71.26 | -93.41 | -128.41 | -145.08 | -116.51 | -108.23 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.7 | -0.48 | -0.27 | -0.58 | -0.7 | -0.31 |
Cash Acquisitions | - | - | - | - | -53 | - |
Investing Cash Flow | -0.7 | -0.48 | -0.27 | -0.58 | -53.7 | -0.31 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 330 | - | 85 | 45 | - |
Long-Term Debt Repaid | - | -334.11 | -0.99 | - | - | - |
Total Debt Repaid | -283.09 | -334.11 | -0.99 | - | - | - |
Net Debt Issued (Repaid) | -3.09 | -4.11 | -0.99 | 85 | 45 | - |
Issuance of Common Stock | 118.25 | 127.46 | 71.46 | 271.17 | 250.01 | 11.84 |
Repurchase of Common Stock | -14.02 | -7.11 | -3.95 | -1.84 | -0.53 | -0.18 |
Other Financing Activities | -12.35 | -14.78 | -8.68 | -23.32 | -9.9 | -0.53 |
Financing Cash Flow | 88.79 | 101.47 | 57.84 | 331.01 | 284.58 | 11.13 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 16.83 | 7.58 | -70.84 | 185.35 | 114.37 | -97.4 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -71.96 | -93.89 | -128.68 | -145.66 | -117.21 | -108.53 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -9.27% | -14.70% | -33.36% | -53.83% | -234.25% | - |
Free Cash Flow Per Share | -1.41 | -1.89 | -2.69 | -3.21 | -2.88 | -2.88 |
Levered Free Cash Flow | -4.58 | -29.42 | -38.1 | -87.21 | -43.82 | -59.52 |
Unlevered Free Cash Flow | 2.82 | -20.77 | -27.25 | -77.26 | -39.26 | -57.04 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 12.24 | 14.63 | 19.69 | 16.73 | 7.69 | 4.63 |
Change in Working Capital | 6.86 | -23.06 | 33.48 | -28.24 | 23.67 | 0.32 |